OI-103

N/A

Report date: 2025/01/26 16:03:03

Base Information

Drug NameOI-103
Drug Alias NameHSC-NK (Oncoinsight)hematopoietic stem cell-derived allogeneic natural killer cell therapy (Oncoinsight)OI-103
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionImmunostimulantsNatural killer cells stimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncoinsight Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOncoinsight Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A